CPAP Therapy May Reduce Hypertensive Disorders of Pregnancy by More than 30%: Meta-Analysis
Obstructive sleep apnea during pregnancy increases risk for gestational hypertension and preeclampsia; CPAP therapy may lower risk significantly.
Mpox Outbreak: 5 Things to Know if Patients Ask
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
Tirzepatide Tied to Lower Risk for Death, Adverse CV and Kidney Outcomes vs GLP-1s: Daily Dose
Your daily dose of the clinical news you may have missed.
Combination Statin Plus Ezetimibe More Effective than High-Dose Statin to Reduce LDL-C in People with ASCVD
In secondary CVD prevention, low/moderate-dose statins plus ezetimibe were superior to high-dose statin for reducing biomarkers, myalgias but did not reduce MACE.
Obesity in the Time of COVID: Expert Insights on the Physical, Emotional Toll on Patients
Patients with obesity face both physical and emotional challenges during the COVID-19 pandemic. How can PCPs help?
FDA Grants Approval, EUA for Updated mRNA COVID-19 Vaccines
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
8 Questions on Updates to the 2024 ACIP Adult Immunization Schedule
Do you know the ACIP-preferred influenza vaccine for adults aged ≥65 yrs? The cut-off age for HPV vaccination? The time between the 2-dose mpox series? More, here.
Alternative Lung Cancer Screening Criteria Expand Eligible Population vs USPSTF Guidance
Simple criteria for lung cancer screening identified more people who would highly benefit, including more from racial/ethnic minority groups.
PCP Visits After Cancer Surgery May Lower Mortality Risk in Older Adults: Daily Dose
Aspirin Use for Colorectal Cancer Prevention May Benefit Unhealthy Individuals Most
Regular aspirin use was associated with a greater absolute reduction in CRC incidence among adults with unhealthier lifestyles, according to recent research.
FDA Approves Neffy as First Nasal Spray for Allergic Reactions: Daily Dose
Tirzepatide Cuts Risk of Progression to T2D by 94% Over 3 Years in Adults with Obesity, Overweight
Results of the 3-year SURMOUNT-1 study reflect the longest trial to date of tirzepatide in adults with overweight/obesity and risk for developing T2D.
PTSD May be a Modifiable Risk Factor for Poor T2D Outcomes
Younger US veterans with PTSD and type 2 diabetes who no longer met criteria for PTSD were less likely to initiate insulin and had reduced odds of mortality.
Cardiovascular Disease Prevention in Patients with Obesity: An Expert Perspective
Anila Chadha, MD, highlights key preventive strategies to reduce CVD risk in patients with obesity and how to tailor them to address individual patient needs.
Likelihood of a Dementia Diagnosis Highly Influenced by Geography: New Research
Investigators found as much as a 2-fold difference in being diagnosed with dementia across the US, even after controlling for common individual risk factors.
Cancer Deaths Among Men Projected to Increase 93% Globally by 2050, According to New Data
Researchers observed substantial disparities in burden by cancer type, age group, countries/territories, and a country's level of Human Development Index.
Undetected Mental Health Diagnoses in US Youth Suicides: Daily Dose
Pfizer/BioNTech Combination Flu/COVID-19 Shot Misses Key Primary Phase 3 Endpoint
The influenza/COVID-19 combination did not prove noninferior to the comparator flu vaccine against influenza B, the companies reported.
Type 1 Diabetes: The High Price of Not Knowing
Primary care clinicians can screen at-risk individuals for type 1 diabetes with a single autoantibody panel. It pays to test and educate early, according to this author.
FDA Accepts Vertex NDA for Suzetrigine, Investigational Oral Nonopioid Analgesic for Acute pain
If approved the selective NaV1.8 pain signal inhibitor would reflect the first new class of pain management medication in more than 20 years.
